Sab Biotherapeutics Inc. Intrinsic Value

SABS

Sab Biotherapeutics fair value

None of the figures this calculator works from (earnings, free cash flow, revenue, book value, dividends) is positive for Sab Biotherapeutics today, so there is nothing to project yet.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with SABS

CompareIntrinsic value

SCNIScinai Immunotherapeutics Ltd.

$0.45-4.92%30

INBXInhibrx Biosciences, Inc.

$86.76+7.01%15

OTLKOutlook Therapeutics Inc.

$0.46+0.46%10

PLURPluri Inc.

$1.23-3.15%30

PROKProKidney Corp

$1.12+4.67%10

IMAImageneBio, Inc.

$4.10+1.99%10

HUMAHumacyte, Inc.

$0.45+2.04%10

CRDFCardiff Oncology Inc.

$0.87+1.03%36

Held by ETFs

SABS is in 2 US ETFs. The largest of them, with SABS's weight in each:

Spot a number that looks wrong? Check it in SABS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing SABS

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.